CureVac N.V. (CVAC)

CureVac Statistics

Total Valuation

CureVac has a market cap or net worth of $573.12 million. The enterprise value is $383.38 million.

Market Cap	573.12M
Enterprise Value	383.38M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CureVac has 224.31 million shares outstanding. The number of shares has increased by 9.65% in one year.

Current Share Class	224.31M
Shares Outstanding	224.31M
Shares Change (YoY)	+9.65%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	6.24%
Owned by Institutions (%)	18.56%
Float	123.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.91
Forward PS	n/a
PB Ratio	1.38
P/TBV Ratio	1.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.10.

Current Ratio	2.29
Quick Ratio	2.19
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.30% and return on invested capital (ROIC) is -32.31%.

Return on Equity (ROE)	-54.30%
Return on Assets (ROA)	-24.52%
Return on Capital (ROIC)	-32.31%
Revenue Per Employee	$60,210
Profits Per Employee	-$254,547
Employee Count	1,172
Asset Turnover	0.09
Inventory Turnover	13.43

Taxes

In the past 12 months, CureVac has paid $2.29 million in taxes.

Income Tax	2.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.13% in the last 52 weeks. The beta is 2.61, so CureVac's price volatility has been higher than the market average.

Beta (5Y)	2.61
52-Week Price Change	-54.13%
50-Day Moving Average	2.89
200-Day Moving Average	3.20
Relative Strength Index (RSI)	38.90
Average Volume (20 Days)	556,794

Short Selling Information

The latest short interest is 4.56 million, so 2.03% of the outstanding shares have been sold short.

Short Interest	4.56M
Short Previous Month	4.71M
Short % of Shares Out	2.03%
Short % of Float	3.69%
Short Ratio (days to cover)	12.68

Income Statement

In the last 12 months, CureVac had revenue of $70.57 million and -$298.33 million in losses. Loss per share was -$1.33.

Revenue	70.57M
Gross Profit	-92.44M
Operating Income	-306.05M
Pretax Income	-297.84M
Net Income	-298.33M
EBITDA	-289.66M
EBIT	-306.05M
Loss Per Share	-$1.33

Balance Sheet

The company has $216.99 million in cash and $41.82 million in debt, giving a net cash position of $175.16 million or $0.78 per share.

Cash & Cash Equivalents	216.99M
Total Debt	41.82M
Net Cash	175.16M
Net Cash Per Share	$0.78
Equity (Book Value)	403.44M
Book Value Per Share	1.80
Working Capital	151.69M

Cash Flow

In the last 12 months, operating cash flow was -$310.57 million and capital expenditures -$35.99 million, giving a free cash flow of -$340.75 million.

Operating Cash Flow	-310.57M
Capital Expenditures	-35.99M
Free Cash Flow	-340.75M
FCF Per Share	-$1.52

Margins

Gross Margin	-131.00%
Operating Margin	-433.71%
Pretax Margin	-419.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-527.11%

Dividends & Yields

CureVac does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.65%
Shareholder Yield	-9.65%
Earnings Yield	-53.20%
FCF Yield	-60.76%

Analyst Forecast

The average price target for CureVac is $10.00, which is 291.39% higher than the current price. The consensus rating is "Hold".

Price Target	$10.00
Price Target Difference	291.39%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	18.76%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CureVac has an Altman Z-Score of -1.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.94
Piotroski F-Score	2